HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > RNCOS

Print e mail rss del Y! myWeb Tweet
 

Global Protein Therapeutics Industry Set for Stupendous Upsurge by 2013

With the advent of new technologies and genetic & chemical techniques, the global protein therapeutics market will grow at a CAGR of 12% during 2010-2013, projects RNCOS.

 



(EMAILWIRE.COM, May 18, 2010 ) New Delhi, India - As per our new research report titled “Global Protein Therapeutics Market Analysis”, the global protein therapeutics market will again revive in 2010 after showing a decline in 2009 amid global financial turmoil. Extensive research and profound analysis performed exhibited a market with high growth potential. With the increasing demand for innovative protein therapeutics each year coupled with huge investments by the market players, it is anticipated that the market will grow at a CAGR of around 12% during 2010-2013.

We have done thorough research and prudent analysis of global protein therapeutics market and identified some critical factors acting as a catalyst for the industry’s current and future growth outlook. The report reveals that increase in the health insurance industry will drive renewed interests of the investors in the therapeutics market at the global level. Moreover, higher incidence of lifestyle and chronic diseases, such as diabetes, cancer, arthritis, etc., will pave the growth of the market in coming years. Based on some concrete market fundamentals, we anticipate that the global protein therapeutics industry will witness worldwide consolidation during our forecast period and will become one of the most dominating market segments in the healthcare industry.

The systematic and thorough research report from RNCOS studies the global protein therapeutics market to give an insight into its various segments, including Monoclonal Antibodies, Erythropoietins, Insulin, Interferon, Human Growth Hormone, Blood Clotting Factor, Granulocyte Colony Stimulating Factor and Follicle Stimulating Hormone. The comprehensive analysis of the market states monoclonal antibodies as the highest share-holder at present, but future will see insulin segment posting a rapid growth.

"Global Protein Therapeutics Market Analysis" provides thorough research and rational analysis along with reliable statistics of the global protein therapeutics industry. The report also provides extensive information on the traditional markets as well as on the emerging technologies. Also, an insight of trends prevailing in the regional protein therapeutics market segments across the globe has been covered in the report. Analysis and statistics regarding market size, growth, share, segmentation and geographic distribution have been thoroughly studied in the report to give a comprehensive view of the market. The report has thoroughly examined the current market trends, industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM557.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012